Latent Viral Infection of Lymphoid Cells in Idiopathic Nephrotic Syndrome (Nephrovir)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The primary purpose of the study is to evaluate the association of a latent infection of lymphoid cells during the first manifestation of steroid sensitive nephrite syndrome. The thirty nine units of general pediatrics and pediatric nephrite covering the parisian area will participate to the study. We speculate that hybridization of the genome, or a part of the genome, of a virus in lymphoid cells is responsible specific changes of genes expression, leading to the development of the disease.
| Condition |
|---|
|
NEPHROSIS, LIPOID |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
| Official Title: | Viral Infection of Lymphoid Cells Occuring at the First Manifestation of Idiopathic Nephrotic Syndrome |
- Hybridization of viral genome will be studied at the first manifestation of idiopathic nephrotic syndrome [ Time Frame: Within the 3 days of the first manifestation ] [ Designated as safety issue: No ]
- Steroid sensitivity will be checked by 1 month of prednisone therapy according to the recommendation of the " SOCIETE DE NEPROLOGIE PEDIATRIQUE" and steroid dependency will be checked at 4.5 months of prednisone therapy. [ Time Frame: 4.5 months ] [ Designated as safety issue: No ]
Biospecimen Retention: Samples With DNA
whole blood, serum, red cells and DNA
| Enrollment: | 401 |
| Study Start Date: | December 2007 |
| Study Completion Date: | February 2012 |
| Primary Completion Date: | July 2010 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
1
Case : Patients with steroid sensitive nephrotic syndrome
|
|
2
Controls (matched for age and sexe with the first group)
|
Detailed Description:
An additional blood volume will be sampled in patients and controls during a scheduled biological check-up for the initial disease and viral genome of EBV, CMV, HHV6, HHV7 as well as adenovirus will be searched for using PCR reaction in total blood DNA extract. The frequency of a latent hybridization of virus genome within human genome will be compared between patients with steroid sensitive nephrotic syndrome and controls matched for age and sex. Secondary studies will include a comparison of steroid dependency in nephrotic patients according to the occurence of a latent viral hybridization, the epidemiology of idiopathic nephrotic syndrome in the Parisian area and a pharmacogenetic analysis of steroid sensitivity and dependency. If necessary, the chromosomal localization of viral hybridization will be studied with fluorescence in situ hybridization using specific probes.
Eligibility| Ages Eligible for Study: | 1 Year to 16 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
From the thirty nine units of general pediatrics and pediatric nephrology covering the Parisian area
Inclusion Criteria:
- proteinuria over 0.25 g/mmol of creatinine with hypoalbuminemia below 30g/L for the case
- No history of renal disease
- Normal C3 and negativity for hepatitis B and C
Exclusion Criteria:
- no medical insurance
- inclusion in another study
Contacts and Locations| France | |
| Hospital Robert Debre | |
| Paris, France, 75945 | |
| Principal Investigator: | Georges DESCHENES, PHD | Assistance Publique - Hôpitaux de Paris |
More Information
Publications:
| Responsible Party: | Assistance Publique - Hôpitaux de Paris |
| ClinicalTrials.gov Identifier: | NCT00577525 History of Changes |
| Other Study ID Numbers: | P070126 |
| Study First Received: | December 19, 2007 |
| Last Updated: | March 7, 2013 |
| Health Authority: | France: Ministry of Health |
Keywords provided by Assistance Publique - Hôpitaux de Paris:
|
LATENT VIRAL INFECTION GENOME HYBRIDIZATION HERPES VIRUS ADENOVIRUS |
Additional relevant MeSH terms:
|
Nephrosis Nephrosis, Lipoid Nephrotic Syndrome |
Virus Diseases Kidney Diseases Urologic Diseases |
ClinicalTrials.gov processed this record on May 16, 2013